Auditor @auditor112017
Retired Internal Auditor (CISA), Accountant, and Info Sec Engineer. Followed biotech, pharma, banking and tech sectors for more than 25 years. Joined October 2017-
Tweets4K
-
Followers185
-
Following26
-
Likes2K
$ions Interesting development with $mgx! finance.yahoo.com/news/metagenom…
$ions "If you actually want to reduce a patient's risk for a heart attack or stroke, you would like to see a reduction in apoB, ..." Reduced by 18%! acc.org/latest-in-card…
This should be good news for $ions and $biib. endpts.com/amylyx-to-volu…
Big pharmas are making billions from their weight loss drugs targeting GLP-1 and glucagon receptors. What's happening with $ions IONIS-GCGR drug which is licensed (2017) to Suzhou Ribo Life Science? Can $ions take this back and start work on it with their new tech?
$sgmo Looks like a flagpole pattern forming. Looks more like a pennant pattern at this point.
$ions Designer DNA Drug Therapy for Neurodegenerative Disease - Dr. Don W. Cleveland youtube.com/watch?v=jmDcjz…
$ions "... FDA Breakthrough designated implantable medical device in clinical development to enable routine subcutaneous administration of therapeutics to the cerebrospinal fluid to potentially improve patient experience." alcyonetx.com/companynews/al…
$ions ION224 (DGAT2) phase 2 to treat patients with NASH. This LICA version should do much better than their older ASO version. Data readout should be coming out soon. I've high expectations for this one. clinicaltrials.gov/study/NCT04932…
Chris Kicks & Crypto @chayt30
732 Followers 2K Following $DOGE $XRP SPED educator/Behavioral Director-nonprofit. Sneakerhead with dope collection. #dogearmy. 🐕🚀🌕 TCU/UNT. $ADA $VET $MATIC $ATOM
tradeswithtom @tradewfxtom
2K Followers 582 Following
Dirk Haussecker @RNAiAnalystz
71 Followers 688 Following Natural born biotech stock trader/investor. Trained in RNAi, extremely excited about RNA Editing. Not investment advice
Godwinsol @godwinsoll
120 Followers 323 Following MD in Oncology. MLaw Jurist & Msc Economist with health law & policy focus. Biopharma investor enthusiast. Views are my own. No investing advice
Jesper Henrichsen @K4lken
70 Followers 125 Following
Alex Prokop @AlexProkop9
60 Followers 281 Following
Al @Bullstk34
1 Followers 88 Following
Del Lago @gtsacks1
44 Followers 1K Following
tim finn @macktavish
625 Followers 5K Following
Ibe @Dark_Stormy23
22 Followers 2K Following Father to Micah. Real Estate Agent. RE investor. Life Science Enthusiast/Investor. Jacksonville, FL. To dine with classes serve the masses. Gunners at ❤️
Tommy Shelby's Godchi.. @kryogod
10 Followers 841 Following Committed husband and devoted father, never doubt it. Be a man and look after your family like Tommy fookin' Shelby.
Plays well with stock.. @PlaysWithStocks
188 Followers 302 Following Not financial advice. Always do DD. Trading is a psychological game. Don't lose against yourself. #daytrading #scalping #momentum #SmallCaps #PreMarket
Romain oRBite Bodinie.. @RBodinier
279 Followers 229 Following (Bio(Tech)Bio) analyst at @AtonRaPartners ¦ ex-President: @swissesports @Geneva_ESPORT¦ MSc Bioengineer/Ph.D Biology ¦ Tweets are my own.
Biotech_optimist @Bio_optimist
84 Followers 127 Following MSc Immunology & Immunotherapy / Long investor (individual) / Biopharma VC analyst
Zeng Jay @jay675216
65 Followers 402 Following
Paul Marganski @paulBIOgeek
55 Followers 183 Following I am interested in technology, biotech, finance, networking, business development, and anything interesting.
mikiass @mikiass0
58 Followers 656 Following
JT @JerryTa90776677
36 Followers 256 Following
Mitchell Reed @MitchellReed09
783 Followers 501 Following Hockey Player Proud Dad Husband and Hardcore Oregon Ducks Fan
HeLa Papi 🔬 @HeLaPapi
247 Followers 526 Following not a doctor and not financial advice. looking for more cowbell in the healthcare arena: trust the bioprocess!
SPACE CHOCOLATE BOY �.. @colossusbiology
84 Followers 301 Following Since everything is made out of atoms produced by the stars, evolution of intelligent life is stars watching their siblings die, then get up & study themselves.
sharply curiosity @Rossteam2012
98 Followers 5K Following Discussions are fine Rational person can disagree Insults are of no interest
BioBoyScout @BioBoyScout
3K Followers 875 Following Independent Biotech Analyst & Patent Atty. Robert Toczycki, JD, MBA. Developer of online biotech valuation calculators. Chicago native. Opinions my own. RNAi
Mahesh Tawney @MaheshTawney
5 Followers 93 Following
bailey007 @bailey007_
2 Followers 2K Following
Kook Han @KookHan10
56 Followers 477 Following
Eulers Analyst @EulersAnalyst
268 Followers 974 Following
Surojit Chakraverti @surochakraverti
357 Followers 3K Following Investor with focus on fundamentals supported by TA & macro. PM, Health & Tech Hedge Fund. Founder at 2x startups. Tweets not recommendations. Opinions my own
Redial @down_dogdiv
58 Followers 410 Following
Ally Bratzel @abratzel
45 Followers 4K Following
AIMO @AIMO92827894
318 Followers 278 Following 核酸医薬関連の情報を共有していきます。 外資製薬→ベンチャー→大学→内資製薬 #製薬, #研究, #核酸医薬
JoeT Pharm.D. @JoeT_PharmD
6 Followers 36 Following
throwaway news @throwawaynews1
0 Followers 2K Following
DAvid Kasahara @kasahara1733
375 Followers 2K Following Pulmonary scientist with passion on drug discovery & development, HSPH alumni, former UVM trainee, and USP graduated. Brazilian ex-pat.
BioKarl @BioKreckel4752
187 Followers 462 Following
kindof @jacekkarczewsk1
4 Followers 1K Following
kahwai @kahwai222
56 Followers 1K Following
Cloudguard08 @Cloudguard08
0 Followers 33 Following
Franz Bertholoi @FranzBertholoi
43 Followers 161 Following
Jamie Dulaney @JamieSoftware
113 Followers 125 Following
Asimpleguy @gibsonchiang
505 Followers 5K Following Lifelong learner and student...Sit tight and read.... https://t.co/q6ya1xK8rO
David R. Liu @davidrliu
64K Followers 59 Following Professor at Harvard, Broad Institute, & HHMI. Our lab integrates chemistry & evolution to illuminate biology & enable new therapeutics. IG/Threads: @davidrliu1
Tucker Carlson @TuckerCarlson
12.9M Followers 1 Following
Phoenix Biotech @BiotechAnalysst
3K Followers 187 Following
Professor Oak @Prof_Oak_
8K Followers 651 Following Biopharma Musings | Genetic Medicine & Rare Disease | Buyside Turned Operator | Not Investment Advice | DYODD
Punit Seth @oligochemist
231 Followers 154 Following Creating new oligo modifications and delivery strategies to enable RNA therapeutics - Views expressed are my own
BioWorld @BioWorld
39K Followers 9K Following Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline Richards
FiercePharma @FiercePharma
98K Followers 485 Following Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.
Breaking Biotech @MatthewLepoire
2K Followers 415 Following Biotech investor/trader - Host of Breaking Biotech (Biweekly podcast) https://t.co/P6wtEkWe07 [email protected]
Ionis Clinical Trials @IonisTrials
87 Followers 24 Following Delivering innovative medicines to patients where no others have proven effective or existed. See our community guidelines: https://t.co/i6ExQuT1vn
IBM News @IBMNews
119K Followers 464 Following Official hub for all that's new + noteworthy about @IBM's business, tech and people. 📰 Subscribe to our newsletter: https://t.co/j4JXnAGzBC
AnnemiekeAartsma-Rus @oligogirl
3K Followers 486 Following Translating science from bench to bedside and from jargon to lay language
Petra Disterer, MSc, .. @PDisterer
398 Followers 285 Following Science writer for the Oligonucleotide Therapeutics Society; Honorary Senior Research Associate at UCL
BIO-SPAC @spaddyman1
172 Followers 220 Following Student of the market. Currently SPACS and biotech and energy Tweets are Opinions and entertainment, not advice. Do your own DD and trade your own plan.
Art Krieg @ArtKrieg
3K Followers 513 Following Developing CpG oligos for cancer immunotherapy, excited about the potential of oligonucleotide therapeutics, love trail running. Tweets are my own.
RNA Therapeutics Inst.. @RTI_UMassChan
5K Followers 1K Following RNA Therapeutics Institute @UMassChan; Uniting nucleic acid scientists w/clinicians to devise human therapies. Loving RNA before it was cool. #RNATx23
Antisense News & Rese.. @antisense_bio
150 Followers 38 Following Track the latest #Antisense news, research, clinical trials, companies and reports. Continuously updated from 500+ news, research publications.
Stanley Crooke, M.D.,.. @DrStanleyCrooke
1K Followers 571 Following Founder and CEO of n-Lorem Foundation. Answering the challenge of treating patients with nano-rare diseases. Opinions are my own.
Brett P. Monia, Ph.D. @BPMonia
518 Followers 304 Following CEO @ionispharma committed to developing therapeutic breakthroughs. Scientific Advisor @OTSociety. BOD @Dynacure & @CogRx. Adjunct Prof @SDSU. Opinions = my own
Oligonucleotide Thera.. @OTSociety
4K Followers 1K Following A nonprofit forum to foster academia and industry based research and development of oligonucleotide therapeutics.
BioBoyScout @BioBoyScout
3K Followers 875 Following Independent Biotech Analyst & Patent Atty. Robert Toczycki, JD, MBA. Developer of online biotech valuation calculators. Chicago native. Opinions my own. RNAi
Fred Anthony @wallstlobo
43 Followers 59 Following
Ionis @ionispharma
5K Followers 488 Following Delivering innovative medicines to patients where no others have proven effective or existed. See our community guidelines: https://t.co/HWH9JQR41u
David Gruberg @DavidGruberg
855 Followers 3K Following Retired teacher. Democrat & combat vet. Overturn Citizens United! Slava Ukraine!
Akcea Therapeutics @akceatx
1K Followers 137 Following Akcea Therapeutics is a wholly owned subsidiary of Ionis Pharmaceuticals. We encourage you to follow @ionispharma for news and updates.
Dirk Haussecker @RNAiAnalyst
18K Followers 508 Following There are no alternative truths. Please do not allow evil to spread and destroy our freedom of life. Not investment advice$PFE reports tomorrow, good chance they take out $SGMO finaly to just spare the $220M milestone for Hemo A GT now after HemoB GT was approved $PFE gets a Phase3 ready Fabry GT (late stage would still fit) also sickle cell GT would be complimentary, as well as multiple platforms
@MitchellReed09 @GamalielBaer @BiotechAnalysst Guys the only conclusion I gained is that $Sgmo is trading below its value ;-) 😉 😘 Agreement???
@RNAiAnalyst @JohnIII39374266 - #hemA is exclusively in the hands of $PFE (yesterday's approval of Fidanacogene Elaparvovec for #HemB demonstrates Pfizer commitment to #genetherapy and #Hemophilia)! $SGMO is in negotiations to sell/partner #Fabry - but for a fair price not as a free giveaway ...
$sgmo happy to see $pfe committment to #hemophilia gene therapy and commercialization. Now makes even more sense to add/commercialize hemophilia A licensed from $sgmo. Mid-24 make-or-break readout. investors.pfizer.com/Investors/News…
@RNAiAnalyst SM pivoted ZFs to targets (nuero Brain barier) where CRISPRs can't go. that is strategicly astute. Drought of cash 4 all biotech & speculative (none positive earnings) companies is macro beyond his control. Academics love of CRISPRs ease/cost is backdrop any CEO must endure $SGMO
$SGMO Epigenetic control of multiple genes with a single lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays cell.com/molecular-ther…
looks like $BMRN roctavian is dead , with the lowered ABR data , the liver monitorin , the alcohol prohibition , the steroids ... and the $SGMO $PFE competition every patient is waiting for with imminent readout in the next few weeks
highly unrealistic $BMRN would be able to even achieve the lower bound of the guidance range ($50M) Lifestyle commitments (setting aside time to attend follow-up appointments for monitoring of F8 + liver enzymes, abstaining/limiting #alcohol use, preventingpregnancy
FDA Marks #Accelerated #approval buckets "something you can measure that correlates w aspect of health #just #measuring that product you know the #gene #therapy will be #Effective up/downstream marker that can be used to measure treatment’s effects $SGMO raps.org/news-and-artic…
$SGMO $SRPT CBER to publish draft guidance for #platform #technologies and develop draft guidance on application of #accelerated #approval to rare disease gene therapies and #genome #editing platforms #CoGenT streamline regulatory process already crosstalk between #FDA and #EMA
@BehaviorFin @Abby10Smalls @BiotechAnalysst I would speculate it isn't the R2000 but #ASGCT2024 abstract 1012 "with the AAV-PRV capsid" and the mentioned Prevail ( $LLY ) capsid is a $SGMO #AAV #capsid Exciting conference ahead for @SangamoTx annualmeeting.asgct.org/abstracts/abst…
$SGMO Meme commemorating my decision to make a onychomycosis cure, simply a proven ABx in novel delivery vehicle, a bigger position than a Fabry gene therapy cure that the FDA granted a first ever accelerated approval single arm Ph 3 pathway to, based on response in the Ph2 data
$IONS Phase 2 trial w/est Apr completion date NCT03815825: clinicaltrials.gov/study/NCT03815… Trial Tracker: fdatracker.com/trial-tracker/
@auditor112017 @CrweWorld allow $SGMO target the human genome every 10kb w potential to target the first intron of most disease-related human alleles in cases where other gene editing approaches are insufficient as means of correcting multiple mutations +to address multiple patient populations at once
@DesertDweller93 @badgerbob777 $SGMO to name one. $110 M market cap. Recently diluted (still a cash issue but should be enough to finalize a partnership or milestone). Phase 3 readout with Pfizer mid 2024 Phase 3 ready Fabry - awaiting partner. + Tregs and Neurology programs
Wonderful $sgmo.
$SGMO Fabry: Cin. Childrens "evidence of improvement in biomarkers, proof of improvement in the health-related quality of life + #stable #function in the #major #organ involvement that we've looked at. The next steps phase 3 trial... in the near future. cgtlive.com/view/improving…
$SGMO Fabry: Cin. Childrens "evidence of improvement in biomarkers, proof of improvement in the health-related quality of life + #stable #function in the #major #organ involvement that we've looked at. The next steps phase 3 trial... in the near future. cgtlive.com/view/improving…
@GamalielBaer @BiotechAnalysst @EricTopol @SangamoTx That #CRISPR goddess #Doudna doesn't mention #ZFP and therefore @SangamoTx - no surprise. More shocking than ignoring $SGMO was not mention @chromamedicine! She discussed the #epigenetic work of Chroma founders @davidrliu & Angelo Lombardo wich used #zincfingers as the key tool
$SGMO Ownership over time 2022-24... HT @ Herr_Chicken
@wyv_123 @mil30557647 @wkissel @jayabacus Your post isn't ruling out, that you understand #trading and #chart analysis.... however it clearly shows that you understand NOTHING of the #Biotech and #Pharma business... $SGMO has three very different programs in the clinic.... all of them proceeding quite smoothly....
$RARE There is something to be said about #antisense and upregulation in the CNS. I'm intrigued! Opportunity looks similar to my new fave, $STOK, but more competition in Angelman's: $IONS #Roche.
From yesterday: Emil Kakkis on the current state of rare disease drug development. See the whole interview: biotechtv.com/post/ultrageny…
Trends for United States
You might like
